CB Therapeutics steps in it.... major IP issue! The original paper from which CB seems to have borrowed without attribution is by Dr. Janis Fricke, Dr. Felix Blei (currently VP for Analytics and co-founder of Mimosa Therapeutics and founder of MIRACULIX), and Dr. Dirk Hoffmeister. Fricke and his colleagues had decided to publish rather than patent this technology in their best effort to make sure that this gift would not become a restrictive patent. Kudos to Graham Pechenik for spotting this. Question: would security laws have been violated if CB had raised its recently closed Series A partially based on representations regarding IP that actually turned out to be... #psychedelics #patents #securitieslaw
James Keim’s Post
See other posts by James
-
James Keim reposted this
I'm thrilled to announce that Bill Brennan has joined our advisory board along with Derek A. and James Keim. Bill brings incredible experience and talent to advise us. He is co-developer at Embark Approach Model for Facilitator Training. He has trained over 30 facilitators. He previously served on the #ethics working group at APPA (American Psychedelic Practitioners Association). Ethics is an urgent thing for us at MINDLUMEN. Our unique approach is creating an observable and measurable Ethics Reputation System (#ERScore). You can learn more about Bill Brennan here: https://lnkd.in/gAMA_YyR We look forward to working with our advisors and looking to add more diverse #ethics experts to our team. Welcome Bill!
About — Mindlumen
mindlumen.xyz
-
Really clever design showing the efficacy of ketamine!
Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients
medrxiv.org
-
Psychedelic mycelium grown in bioreactors is back. New versions, with and without psilocybin, are available as law permits. The consistent potency, neutral taste, and exotic species are a clinician's dream. Our new company is offering a modern rendition of the work of Catafolmo and peers (back in the 1960's), and we are looking for partners who want to help to share the love.
-
-
Psychedelic Medicine Advocate, #1 Amazon Best Selling Author, Collaborative Leader & Entrepreneur
It's fantastic to see the latest issue (March) of #StanfordMagazine featuring the use of psychedelics for mental health. The article "Falling for Psychedelics" by Tracie White explores the growing interest in psychedelic drugs for therapeutic purposes. The author profiles several individuals who have struggled with mental health issues and have turned to psychedelics such as psilocybin and MDMA for treatment. The article delves into the research conducted at Stanford University and other institutions to study the potential benefits and risks of using psychedelics in a clinical setting. Overall, it examines the complex issues surrounding using psychedelics for therapeutic purposes and highlights the need for further research. Learn more about the potential benefits of using psychedelic drugs for therapeutic purposes by reading Tracie White's article. https://lnkd.in/gH-JbA9X #microdosing #psychedelicmedicine #psychedelictreatment #naturaltreatment #addictiontherapy #adaptogens #addictionrecovery #microdosis #anxiety #anxietyrelief #mattzemon #mentalhealth #standford
-
-
What many have been saying….
The Latest Promising Long COVID Treatment? Psychedelic Drugs — TIME
apple.news
-
A peek inside the largest mycelium factory ever conceived 👀 Our first full-scale Fine Mycelium factory is under construction in South Carolina with a capacity of 50,000 trays outputting millions of square feet of our material per year! Come grow with us: https://lnkd.in/eXk4r_t
-
Thanks to everyone for the lively discussion on the ethics of testimonials for psychedelic trials and retreats. I've drawn together many of these opinions in this piece, and made some tentative suggestions for best practices. Let me know what you think. #psychedelicethics #psychedelics #psychedelicharmreduction
The ethics of psychedelic testimonials
ecstaticintegration.substack.com
-
James Keim reposted this
PhD Student at University of Alabama - Birmingham || Co-director of Research & Professional Development at Intercollegiate Psychedelics Network || Science Communicator
We are 75% done recruiting participants for the psychosis and psychedelics study! Please continue to help get the word out about the study by sharing it. 😊 If you are interested in being in the study, you can take the screening survey here: https://lnkd.in/gGYd2F8W Thank you Source Research Foundation for making this possible and Peter Hendricks, PhD and Heith Copes, PhD for helping with the study. #psychosis #psychedelics
-
Initiator, projectmanager, mystagogue.
1yReport
Report
Standing on the shoulders of giant...